TUBB3 and cancer: Taken together, these data indicate that secretome factors from PTX-resistant cancer cells with acquired cross-resistance can sufficiently influence MDR in first-line PTX-resistant cancers cells with impaired FOXO3a-regulated ABCB1 activity and can be predicted by TUBB3 feedback.